Impact of Lymphoedema and Urinary Issues After Cancer Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the incidence and prognostic variables of lower limb lymphoedema and urinary complications such as nocturia and nocturnal polyuria in patients who have undergone pelvic lymph node dissection for urogenital cancers. It aims to identify the most sensitive clinical measurement methods for early detection of lymphoedema and to understand the relationship between cancer treatment and urinary issues. By collecting data on these conditions, the study seeks to improve patient care and quality of life post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Non-metastatic urogenital cancer (i.e. prostate cancer or bladder cancer)
* Planned transperitoneal pelvic lymph node dissection or salvage lymph node dissection
* Salvage lymph node dissection
* Before inclusion, written informed consent must be given according to ICH/GCP, and national/local regulations.

Exclusion Criteria:

* Radiological evidence of metastatic disease based on pelvic CT/MRI and bone scan
* Clinical signs of chronic venous insufficiency (CEAP C3-C6)
* History of lymph node dissection/ radiotherapy at the level of the pelvis or groin

Where it's running

• University Hospitals Leuven, campus Gasthuisberg
  Leuven, Flanders, Belgium Recruiting

Study contacts

• Principal investigator: Nele Devoogdt, Prof. Dr. — UZ Leuven
• Study coordinator: Nele Devoogdt, Prof. Dr.
• Email: nele.devoogdt@uzleuven.be
• Phone: +3216342515

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Compare two bladder medicines and placebo for urgency incontinence in older women

  This study tests whether tolterodine ER or mirabegron help with urinary and aging-related outcomes in older women with urgency-predominant incontinence, compared with placebo.

  Recruiting Phase 4 University of California, San Francisco · San Francisco, California · NCT07829029

• Managing nighttime voiding in older women with sleep strategies

  This study tests whether brief behavioral sleep therapy and mindfulness, alone or together, reduce how often older women wake at night to urinate and how much urine they produce at night.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07760779

• Community-based approach using digital tools and behavioral guidance for nocturia

  This project tests a digital health and behavioral program for adults 55+ with nocturia to see if it reduces night-time voids and improves quality of life.

  Recruiting National Taiwan University Hospital · Douliu · NCT07734207

• Moxibustion at specific points for nighttime urination

  This study tests whether applying heat to acupuncture points (moxibustion) at night can help adults 40 and older who wake up two or more times for urination.

  Recruiting Buddhist Tzu Chi General Hospital · Hualien City · NCT07598227

• Electroacupuncture vs PTNS for women with refractory overactive bladder

  This study tests whether electroacupuncture or percutaneous tibial nerve stimulation can help women whose overactive bladder hasn’t improved with standard therapy.

  Recruiting Chelsea and Westminster NHS Foundation Trust · London, United Kingdom · NCT07124390

• Hydrotherapy for treating unilateral lower limb lymphedema

  This study tests whether adding hydrotherapy to a home exercise program can help people with swelling in one leg feel better and improve their daily activities.

  Recruiting Gaziosmanpasa Research and Education Hospital · Istanbul · NCT06839885

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.